kabutan

Immuno-Biological Laboratories Co., Ltd.(4570) Summary

4570
TSE Growth
Immuno-Biological Laboratories Co., Ltd.
1,459
JPY
-69
(-4.52%)
Dec 12, 3:30 pm JST
9.36
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
1,422
Dec 12, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
51.2
PBR
8.21
Yield
0.41%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,560 JPY 10.03 USD
Previous Close Dec 11
1,528 JPY 9.78 USD
High Dec 12, 9:03 am
1,650 JPY 10.60 USD
Low Dec 12, 1:16 pm
1,407 JPY 9.03 USD
Volume
2,779,300
Trading Value
4.15B JPY 0.03B USD
VWAP
1494.76 JPY 9.59 USD
Minimum Trading Value
145,900 JPY 936 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
9,477
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,719
1-Year High Dec 4, 2025
69,121
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 36,500 1,490,000 40.82
Nov 28, 2025 38,000 767,000 20.18
Nov 21, 2025 22,900 750,100 32.76
Nov 14, 2025 14,500 665,500 45.90
Nov 7, 2025 0 608,900
Company Profile
Immuno-Biological Laboratories Co., Ltd. manufactures and sells research reagents and offers contract services. The silkworm development business has been suspended. The company has entered the cosmetics business.
Sector
Pharmaceuticals
Immuno-Biological Laboratories Co., Ltd. primarily manufactures and sells antibody-based research reagents, in vitro diagnostic pharmaceuticals, and raw materials for in vitro diagnostic pharmaceuticals. The company also develops pharmaceutical seeds utilizing antibody production technology and provides the lipoprotein profiling analysis service "LipoSEARCH". Additionally, the company offers contract services for mass production of proteins and antibodies using genetically modified silkworm technology. Furthermore, in the cosmetics sector, Immuno-Biological Laboratories Co., Ltd. focuses on developing and selling products containing silkworm-derived "NeoSilk-Human Collagen I".